Riad Sherif, CEO of Oculis, gives a company update on clinical trials, financing and other items in the pipeline

Riad Sherif, MD, CEO of Oculis, gives a company update on clinical trials for products in DME, ocular surgery, and more; plus, growing products in glaucoma treatments, team and financing updates.

Related Videos

Related Content

Advertisement

March 29th 2025

Labtician Ophthalmics announces commercial launch of Lab TRIACTIV

December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

March 26th 2025

Nanoscope Therapeutics publishes clinical data on vision restoration in retinitis pigmentosa

November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

March 24th 2025

Unity Biotechnology releases topline results from phase 2b ASPIRE trial of UBX1325 in patients with diabetic macular edema

March 24th 2025

Nicox announces last patient completed final visit in Whistler Phase 3b clinical trial

Related Content

Advertisement

March 29th 2025

Labtician Ophthalmics announces commercial launch of Lab TRIACTIV

December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

March 26th 2025

Nanoscope Therapeutics publishes clinical data on vision restoration in retinitis pigmentosa

November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

March 24th 2025

Unity Biotechnology releases topline results from phase 2b ASPIRE trial of UBX1325 in patients with diabetic macular edema

March 24th 2025

Nicox announces last patient completed final visit in Whistler Phase 3b clinical trial